Shree Ganesh [SGRL] vs Sequent Scientific [SEQUENT] Detailed Stock Comparison
Shree Ganesh
BSE
Loading...
Sequent Scientific
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Shree Ganesh wins in 14 metrics, Sequent Scientific wins in 5 metrics, with 0 ties. Shree Ganesh appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Shree Ganesh | Sequent Scientific | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 30.84 | 166.33 | Shree Ganesh |
| Price-to-Book Ratio | 4.65 | 6.61 | Shree Ganesh |
| Debt-to-Equity Ratio | 26.44 | 62.47 | Shree Ganesh |
| PEG Ratio | -1.19 | 1.40 | Shree Ganesh |
| EV/EBITDA | 17.58 | 30.63 | Shree Ganesh |
| Profit Margin (TTM) | 20.16% | 1.85% | Shree Ganesh |
| Operating Margin (TTM) | 19.77% | 7.56% | Shree Ganesh |
| EBITDA Margin (TTM) | 19.77% | 7.56% | Shree Ganesh |
| Return on Equity | 15.89% | 2.84% | Shree Ganesh |
| Return on Assets (TTM) | 12.02% | 1.37% | Shree Ganesh |
| Free Cash Flow (TTM) | $74.69M | $442.73M | Sequent Scientific |
| 1-Year Return | -38.00% | -10.14% | Sequent Scientific |
| Price-to-Sales Ratio (TTM) | 6.22 | 3.00 | Sequent Scientific |
| Enterprise Value | $6.85B | $50.87B | Sequent Scientific |
| EV/Revenue Ratio | 6.32 | 3.17 | Sequent Scientific |
| Gross Profit Margin (TTM) | 64.62% | 46.86% | Shree Ganesh |
| Revenue per Share (TTM) | $84 | $64 | Shree Ganesh |
| Earnings per Share (Diluted) | $17.03 | $1.12 | Shree Ganesh |
| Beta (Stock Volatility) | 0.20 | 0.91 | Shree Ganesh |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Shree Ganesh vs Sequent Scientific Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Shree Ganesh | -3.10% | -2.27% | -14.23% | -10.95% | -31.40% | -22.63% |
| Sequent Scientific | 1.15% | -8.42% | 9.29% | -3.35% | 37.17% | 0.89% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Shree Ganesh | -38.00% | 112.42% | 294.53% | 1,442.27% | 1,442.27% | 1,442.27% |
| Sequent Scientific | -10.14% | 69.59% | 19.72% | 26.36% | 26.36% | 26.36% |
News Based Sentiment: Shree Ganesh vs Sequent Scientific
Shree Ganesh
News based Sentiment: NEGATIVE
September brought disappointing financial results for Shree Ganesh Remedies, with a significant decline in net profit. Coupled with leadership changes and a falling stock price, the month paints a concerning picture for investors, suggesting potential challenges ahead despite a discounted valuation compared to peers.
Sequent Scientific
News based Sentiment: POSITIVE
Sequent Scientific's impressive Q1 FY2025-26 results, with a 21.9% revenue increase and a massive 1283.5% profit jump, clearly demonstrate a positive shift in the company's financial performance. This strong showing is a significant development for investors, indicating potential for future growth and returns.
Performance & Financial Health Analysis: Shree Ganesh vs Sequent Scientific
| Metric | SGRL | SEQUENT |
|---|---|---|
| Market Information | ||
| Market Cap | ₹6.85B | ₹48.13B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 6,495 | 1,494,055 |
| 90 Day Avg. Volume | 4,949 | 754,164 |
| Last Close | ₹508.95 | ₹186.29 |
| 52 Week Range | ₹494.95 - ₹950.00 | ₹117.35 - ₹240.70 |
| % from 52W High | -46.43% | -22.60% |
| All-Time High | ₹950.05 (Jul 22, 2024) | ₹336.50 (Jun 28, 2021) |
| % from All-Time High | -46.43% | -44.64% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.01% | 0.13% |
| Quarterly Earnings Growth | -0.26% | 1.20% |
| Financial Health | ||
| Profit Margin (TTM) | 0.20% | 0.02% |
| Operating Margin (TTM) | 0.20% | 0.08% |
| Return on Equity (TTM) | 0.16% | 0.03% |
| Debt to Equity (MRQ) | 26.44 | 62.47 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹113.00 | ₹28.19 |
| Cash per Share (MRQ) | ₹22.01 | ₹2.52 |
| Operating Cash Flow (TTM) | ₹337.14M | ₹360.47M |
| Levered Free Cash Flow (TTM) | ₹230.68M | ₹218.78M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | ₹0.00 | ₹0.00 |
Valuation & Enterprise Metrics Analysis: Shree Ganesh vs Sequent Scientific
| Metric | SGRL | SEQUENT |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 30.84 | 166.33 |
| Forward P/E | N/A | 36.89 |
| PEG Ratio | -1.19 | 1.40 |
| Price to Sales (TTM) | 6.22 | 3.00 |
| Price to Book (MRQ) | 4.65 | 6.61 |
| Market Capitalization | ||
| Market Capitalization | ₹6.85B | ₹48.13B |
| Enterprise Value | ₹6.85B | ₹50.87B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 6.32 | 3.17 |
| Enterprise to EBITDA | 17.58 | 30.63 |
| Risk & Other Metrics | ||
| Beta | 0.20 | 0.91 |
| Book Value per Share (MRQ) | ₹113.00 | ₹28.19 |
Financial Statements Comparison: Shree Ganesh vs Sequent Scientific
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SGRL | SEQUENT |
|---|---|---|
| Revenue/Sales | ₹246.68M | ₹4.41B |
| Cost of Goods Sold | ₹87.28M | ₹2.35B |
| Gross Profit | ₹159.40M | ₹2.07B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹48.77M | ₹333.50M |
| EBITDA | ₹79.58M | ₹505.30M |
| Pre-Tax Income | ₹45.98M | ₹255.20M |
| Income Tax | ₹11.53M | ₹79.50M |
| Net Income (Profit) | ₹34.45M | ₹175.70M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SGRL | SEQUENT |
|---|---|---|
| Cash & Equivalents | ₹99.43M | ₹626.60M |
| Total Current Assets | ₹775.75M | ₹8.74B |
| Total Current Liabilities | ₹161.82M | ₹5.05B |
| Long-Term Debt | ₹296.08M | ₹3.00B |
| Total Shareholders Equity | ₹1.45B | ₹7.70B |
| Retained Earnings | ₹1.10B | ₹1.25B |
| Property, Plant & Equipment | ₹31.57M | ₹2.84B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SGRL | SEQUENT |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | SGRL | SEQUENT |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 6,495 | 1,494,055 |
| Average Daily Volume (90 Day) | 4,949 | 754,164 |
| Shares Outstanding | 12.84M | 249.89M |
| Float Shares | 2.20M | 118.88M |
| % Held by Insiders | 0.76% | 0.52% |
| % Held by Institutions | 0.00% | 0.13% |
Dividend Analysis & Yield Comparison: Shree Ganesh vs Sequent Scientific
| Metric | SGRL | SEQUENT |
|---|---|---|
| Last 12-Month Dividend | ₹0.00 | ₹0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | ₹0.33 | ₹0.00 |
| 3-Year Avg Dividend Yield | 0.15% | N/A |
| 3-Year Total Dividends | ₹1.00 | ₹0.00 |
| Ex-Dividend Date | Sep 07, 2023 | N/A |